Advanced search
Publication Cover
Acta Oncologica Volume 53, 2014 - Issue 9
Journal homepage
3,299
Views
29
CrossRef citations to date
0
Altmetric
Psychosocial Oncology-Supportive Care

Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies – systematic review and meta-analysis

Irit Ben-AharonInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petah-Tikva, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
,
Salomon M. StemmerInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petah-Tikva, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Leonard LeiboviciDepartment of Medicine E, Rabin Medical Center, Petah-Tikva, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Ofer ShpilbergSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Aaron SulkesInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petah-Tikva, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
&
Anat Gafter-GviliDepartment of Medicine E, Rabin Medical Center, Petah-Tikva, Israel;Institute of Hematology, Davidoff Center, Rabin Medical Center, Petah-Tikva, Israel;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Pages 1230-1237 | Received 25 Feb 2014, Accepted 16 May 2014, Published online: 27 Aug 2014

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yiwei Wang, Maoyun Wang, Yuenan Ni & Zongan Liang. (2020) Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer. Hematology 25:1, pages 63-70.
Read now
Gali Perl, Baruch Brenner & Irit Ben-Aharon. (2016) Optimal management of venous thromboembolism in advanced pancreatic cancer with low-molecular-weight heparin: current evidence. Gastrointestinal Cancer: Targets and Therapy 6, pages 49-54.
Read now

Articles from other publishers (27)

Hatice Bolek & Yüksel Ürün. (2023) Cancer‐associated thrombosis and drug–drug interactions of antithrombotic and antineoplastic agents. Cancer.
Crossref
Andrés Muñoz, Cihan Ay, Ella Grilz, Sonia López, Carme Font, Vanesa Pachón, Victoria Castellón, Virginia Martínez-Marín, Mercedes Salgado, Eva Martínez, Julia Calzas, Laura Ortega, Ana Rupérez, Eduardo Salas, Ingrid Pabinger & Jose Manuel Soria. (2023) A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. Journal of Clinical Oncology 41:16, pages 2911-2925.
Crossref
Nidhi Dhariwal, Venkata Rama Mohan Gollamudi, K. P. Sangeetha, Badira Cheriyalinkal Parambil, Nirmalya Roy Moulik, Chetan Dhamne, Maya Prasad, Tushar Vora, Girish Chinnaswamy, Seema Kembhavi, Papagudi G. Subramanian, Sumeet Gujral, S. D. Banavali & Gaurav Narula. (2022) Pediatric cancer‐associated thrombosis: Analysis from a tertiary care cancer center in India. Pediatric Blood & Cancer 70:2.
Crossref
Guilherme Yazbek & Bruno Soriano Pignataro. 2022. Vascular Surgery in Oncology. Vascular Surgery in Oncology 439 466 .
Raimondo Di Liello, Laura Arenare, Francesco Raspagliesi, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Simona Frezzini, Germana Tognon, Grazia Artioli, Angiolo Gadducci, Rossella Lauria, Annamaria Ferrero, Saverio Cinieri, Andrea De Censi, Enrico Breda, Paolo Scollo, Ugo De Giorgi, Andrea Alberto Lissoni, Dionyssios Katsaros, Domenica Lorusso, Vanda Salutari, Sabrina Chiara Cecere, Mariateresa Lapresa, Margherita Nardin, Giorgio Bogani, Mariagrazia Distefano, Stefano Greggi, Piera Gargiulo, Clorinda Schettino, Ciro Gallo, Gennaro Daniele, Daniela Califano, Francesco Perrone, Sandro Pignata & Maria Carmela Piccirillo. (2021) Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. International Journal of Gynecologic Cancer 31:10, pages 1348-1355.
Crossref
Nathan Watson & Hanny Al‐Samkari. (2021) Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. Journal of Thrombosis and Haemostasis 19:8, pages 1852-1863.
Crossref
Gary H. LymanMarc Carrier, Cihan AyMarcello Di NisioLisa K. HicksAlok A. KhoranaAndrew D. LeavittAgnes Y. Y. LeeFergus MacbethRebecca L. MorganSimon NobleElizabeth A. SextonDavid Stenehjem, Wojtek Wiercioch, Lara A. Kahale & Pablo Alonso-Coello. (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Advances 5:4, pages 927-974.
Crossref
Anat Gafter-Gvili, Genady Drozdinsky, Oren Zusman, Shiri Kushnir & Leonard Leibovici. (2020) Venous Thromboembolism Prophylaxis in Acute Medically Ill Patients: A Retrospective Cohort Study. The American Journal of Medicine 133:12, pages 1444-1452.e3.
Crossref
Alice Labianca, Tommaso Bosetti, Alice Indini, Giorgia Negrini & Roberto Francesco Labianca. (2020) Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer. Cancers 12:8, pages 2070.
Crossref
Orly Leiva, Jean M. Connors & Hanny Al-Samkari. (2020) Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers 12:7, pages 1958.
Crossref
Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Y.Y. Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Gary H. Lyman & Anna Falanga. (2020) Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology 38:5, pages 496-520.
Crossref
A. J. Muñoz Martín, E. Gallardo Díaz, I. García Escobar, R. Macías Montero, V. Martínez-Marín, V. Pachón Olmos, P. Pérez Segura, T. Quintanar Verdúguez & M. Salgado Fernández. (2020) SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019). Clinical and Translational Oncology 22:2, pages 171-186.
Crossref
Miao Liu, Guiyue Wang, Yuhang Li, Hongliang Wang, Haitao Liu, Nana Guo, Ci Han, Yahui Peng, Mengyuan Yang, Yansong Liu, Xiaohui Ma, Kaijiang Yu & Changsong Wang. (2020) Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology 12, pages 175883592090754.
Crossref
Hailong Chen, Rui Tao, Hui Zhao, Jianjun Jiang & Jin Yang. (2020) Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants. Medicine 99:5, pages e19000.
Crossref
T. Macarulla, A. Carrato, R. Díaz, A. García, B. Laquente, J. Sastre, R. Álvarez, A. Muñoz & M. Hidalgo. (2019) Management and supportive treatment of frail patients with metastatic pancreatic cancer. Journal of Geriatric Oncology 10:3, pages 398-404.
Crossref
F. Ruiz-Ruiz, F.J. Medrano, J.M. Santos-Lozano, P. Rodríguez-Torres, A. Navarro-Puerto & E.J. Calderón. (2019) Anticoagulant treatment of medical patients with complex clinical conditions. Revista Clínica Española (English Edition) 219:1, pages 34-43.
Crossref
F. Ruiz-Ruiz, F.J. Medrano, J.M. Santos-Lozano, P. Rodríguez-Torres, A. Navarro-Puerto & E.J. Calderón. (2019) Tratamiento anticoagulante en pacientes médicos con situaciones clínicas complejas. Revista Clínica Española 219:1, pages 34-43.
Crossref
F. Ruiz-Ruiz, F.J. Medrano, M.A. Navarro-Puerto, P. Rodríguez-Torres, A. Romero-Alonso, J.M. Santos-Lozano, C. Alonso-Ortiz del Rio, J.M. Varela-Aguilar, E.J. Calderón & I. Marín-León. (2018) Delphi-RAND consensus of the Spanish Society of Internal Medicine on the controversies in anticoagulant therapy and prophylaxis in medical diseases. INTROMBIN Project (Uncertainty in thromboprophylaxis in internal medicine). Revista Clínica Española (English Edition) 218:7, pages 358-371.
Crossref
F. Ruiz-Ruiz, F.J. Medrano, M.A Navarro-Puerto, P. Rodríguez-Torres, A. Romero-Alonso, J.M. Santos-Lozano, C. Alonso-Ortiz del Rio, J.M. Varela-Aguilar, E.J. Calderón & I. Marín-León. (2018) Consenso Delphi-RAND de la Sociedad Española de Medicina Interna sobre controversias en terapia y profilaxis anticoagulante en enfermedades médicas. Proyecto INTROMBIN (INcertidumbre en TROMBoprofilaxis en Medicina INterna). Revista Clínica Española 218:7, pages 358-371.
Crossref
Zi-Li Liu, Qian Wang, Ming Wang, Bin Wang & Li-Nian Huang. (2018) Low molecular weight heparin in treating patients with lung cancer received chemotherapy. Journal of Cancer Research and Therapeutics 14:Suppl 2, pages S437-S443.
Crossref
Hikmat Abdel-Razeq & Asem Mansour. (2017) Venous thromboembolism prophylaxis for ambulatory cancer patients, can we do better?. Journal of Thrombosis and Thrombolysis 44:3, pages 399-405.
Crossref
Elie A Akl, Lara A Kahale, Maram B Hakoum, Charbel F Matar, Francesca Sperati, Maddalena Barba, Victor ED Yosuico, Irene Terrenato, Anneliese Synnot & Holger Schünemann. (2017) Parenteral anticoagulation in ambulatory patients with cancer. Cochrane Database of Systematic Reviews 2023:1.
Crossref
Jason M. Foster, Richard Sleightholm, Duncan Watley, Steven Wahlmeier & Asish Patel. (2017) The Efficacy of Dextran-40 as a Venous Thromboembolism Prophylaxis Strategy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. The American Surgeon 83:2, pages 134-140.
Crossref
Dominique Farge, Henri Bounameaux, Benjamin Brenner, Francis Cajfinger, Philippe Debourdeau, Alok A Khorana, Ingrid Pabinger, Susan Solymoss, James Douketis & Ajay Kakkar. (2016) International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology 17:10, pages e452-e466.
Crossref
Nay Min Tun, Elizabeth Guevara & Thein Hlaing Oo. (2016) Benefit and risk of primary thromboprophylaxis in ambulatory patients with advanced pancreatic cancer receiving chemotherapy. Blood Coagulation & Fibrinolysis 27:3, pages 270-274.
Crossref
Barbara Mulloy, John Hogwood, Elaine Gray, Rebecca Lever & Clive P. Page. (2015) Pharmacology of Heparin and Related Drugs. Pharmacological Reviews 68:1, pages 76-141.
Crossref
Sudeep Dhoj Thapa, Hiba Hadid & Mohammad Usman. (2015) Pulmonary Embolism and Stroke as the Initial Manifestation of Advanced Metastatic Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer 46:2, pages 182-184.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.